Debut Biotech is a biotechnology company that focuses on developing a platform for cell-free biocatalysis. It specializes in creating a range of immobilized enzymes for use in manufacturing systems: biomanufacturing cartridges, fermentation, immobilization of cells and enzymes and enzymes for pharmaceutical production and modification.
|Employees (est.) (May 2020)||11|
Debut Biotech total Funding
Debut Biotech latest funding size
Time since last funding
|5 months ago|
Debut Biotech investors
|Better Ventures, Springtide Ventures, KdT Ventures, FTW Ventures|
When was Debut Biotech founded?
Debut Biotech was founded in 2019.
Who are Debut Biotech key executives?
Debut Biotech's key executives are Joshua Britton, Brady Beauchamp and Gregory Weiss.
How many employees does Debut Biotech have?
Debut Biotech has 11 employees.
Who are Debut Biotech competitors?
Competitors of Debut Biotech include Phitonex, Tenaya Therapeutics and FluoroFinder.
Receive alerts for 300+ data fields across thousands of companies